Report
Jonathan Moreland
EUR 9.46 For Business Accounts Only

InsiderInsights Weekly Tables: July 20, 2019

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process
Underlyings
AbbVie Inc.

AbbVie is a research-based biopharmaceutical company. The company's products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. The company also has medicines in clinical development across immunology, oncology and neuroscience, with additional targeted investment in cystic fibrosis and women's health.

AMAG Austria Metall AG

AMAG Austria Metall is a holding company, engaged in the production of primary aluminum, as well as cast and rolled aluminum products. The metal division is responsible for the risk management and steering of the metal flows. The casting division recycles aluminum scrap to produce foundry alloys. Its product portfolio covers aluminum materials tailored to customer requirements in the form of ingots, sows and liquid aluminum. The rolling division is responsible for the production and sale of rolled products, and precision cast and rolled plates. The service division include facility management, energy supplies, waste disposal, and purchasing and materials management.

Angi Inc. Class A

ANGI Homeservices connects homeowners to home service professionals through its portfolio of digital home services brands. The company has two segments: North America (United States and Canada), which includes HomeAdvisor digital marketplace service (HomeAdvisor), Angie's List, its subsidiary, Handy Technologies, Inc. (Handy), mHelpDesk and HomeStars; and Europe, which includes Travaux, MyHammer, My Builder, Werkspot and Instapro. HomeAdvisor provides consumers with tools and resources to help them find local, pre-screened and customer-rated service professionals, as well as book appointments online. Handy connects individuals looking for household services with pre-screened service professionals.

Apellis Pharmaceuticals

Apellis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on treating disease through the inhibition of the complement system, which is a component of the immune system, at the level of C3, the central protein in the complement cascade. The company's clinical program targets C3 with Phase 3 clinical trials of its main product candidate, APL-2, in multiple indications. APL-2 has the potential to be a treatment that address the limitations of existing treatment options or provide a treatment option. The company is also conducting a Phase 2 trial of APL-2 in glomerular diseases, including C3 glomerulopathy, IgA nephropathy, primary membranous nephropathy and lupus nephritis.

Arcus Biosciences

Arcus Biosciences is a clinical-stage biopharmaceutical company focused on creating cancer immunotherapies. The company has four clinical-stage product candidates: AB928, which is an orally bioavailable, reversible antagonist of the adenosine 2a and adenosine 2b receptors; AB680, which is a reversible and selective inhibitor of the CD73 enzyme; AB122, which is a human antibody with similar binding affinity and other characteristics to the marketed anti-PD-1 antibodies pembrolizumab and nivolumab; and AB154, which is a humanized antibody that inhibits an immune checkpoint target involved in a pathway that plays both inhibitory and stimulatory roles in the immune system.

Armstrong Flooring Inc.

Armstrong Flooring is a producer of resilient flooring products for use primarily in the construction and renovation of commercial, residential and institutional buildings. The company designs, manufactures, sources and sells flooring products primarily in North America and the Pacific Rim.

ArQule Inc.

ArQule is a biopharmaceutical company engaged in the research and development of therapeutics to treat cancers and rare diseases. The company's clinical pipeline includes: ARQ 531, which is a reversible dual inhibitor of both wild type and C481S-mutant Bruton's tyrosine kinase for B-cell malignancies refractory to other therapeutic options; Miransertib, which is a selective inhibitor of protein kinase B (AKT) in combination with the hormonal therapy, anastrozole; ARQ 751, which is a selective inhibitor of AKT for solid tumors harboring AKT, phosphoinositide 3-kinase or phosphatase and tensin homolog (PTEN) mutations or that are PTEN null; and Derazantinib, which is a multi-kinase inhibitor.

Ashford Hospitality Trust Inc.

Ashford Hospitality Trust together is an externally-advised real estate investment trust focused on investing in the hospitality industry with a focus predominantly on hotels in the U.S. The company owns its lodging investments and conducts its business through Ashford Hospitality Limited Partnership, its operating partnership. The company is advised by its subsidiary, Ashford Hospitality Advisors LLC (Ashford LLC), through an advisory agreement. All of the hotel properties in the company's portfolio are asset-managed by Ashford LLC. The company's hotel properties are primarily branded under the brands of Hilton, Hyatt, Marriott and Intercontinental Hotels Group.

Beacon Roofing Supply Inc.

Beacon Roofing Supply is a distributor of roofing materials and complementary building products in the United States and Canada. The complementary building products the company distributes include siding, windows, insulation, waterproofing systems, wallboard, acoustical ceilings, and other exterior and interior building products. The company purchases products from manufacturers and then distributes these goods to a customer base consisting of contractors, and to a lesser extent, home builders, retailers, and other building materials suppliers. The company supports its customers with services such as advice and assistance on product identification, specification and technical support, and training services.

Biohaven Pharmaceutical Holding Company Ltd.

BIOPHARMX

BlueLinx Holdings

BlueLinx Holdings is a distributor of building and industrial products. The company operates its distribution business through a network of distribution centers. The company serves various metropolitan areas in the U.S. The company distributes products in two principal categories: structural products and specialty products. Structural products include plywood, oriented strand board, rebar and remesh, lumber, spruce and other wood products primarily used for structural support, walls, and flooring in construction projects. Specialty products include engineered wood products, moulding, siding (including vinyl products), cedar, metal products (excluding rebar and remesh) and insulation.

CalAmp Corp.

CalAmp is a telematics solutions provider. The company's software applications, cloud services, and intelligent devices collect and assess data including industrial machines, commercial and passenger vehicles, their drivers and contents. The company operates under two reportable segments: Telematics Systems, which provide a series of telematics and stolen vehicle recovery products for the connected vehicle and emerging Internet of Machines marketplace; and Software and Subscription Services, which provide cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open Application Programming Interfaces.

Calithera Biosciences Inc.

Calithera Biosciences is a clinical-stage bio-pharmaceutical company focused on fighting cancer and other life threatening diseases by discovering and developing small molecule drugs that targets cellular metabolism. The company's main product candidate, telaglenastat (CB-839), is a selective glutaminase inhibitor that blocks glutamine consumption in tumor cells and demonstrates synergistic antitumor effects with multiple anticancer therapies.Co.'s other product candidate, INCB001158, is an oral inhibitor of arginase, an enzyme that depletes the amino acid arginine, a key metabolic nutrient for T-cells and it is being co-developed with Incyte Corporation, for oncology and hematology indications.

Capital Senior Living Corporation

Capital Senior Living is an operator of senior housing communities. The company provides senior living services, including independent living services, which are provided to seniors who do not yet need assistance, but who prefer the physical and psychological comfort of a residential community that provides health care and other services; assisted living services, which include personal care services, 24-hour staffing, support services, and supplemental services; and memory care services, which maintain programs and living accomodations for residents with certain forms of dementia. The company makes home care services available to clients at its senior housing communities through third-party providers.

Carnival PLC

Carnival plc

Carnival is a leisure travel and cruise company. Co. operates over 100 cruise ships within a portfolio of global, regional and national cruise brands that sell tailored cruise products, services and vacation experiences. Co.'s North America cruise brands include Carnival Cruise Line, Princess Cruises, Holland America Line, and Seabourn. Co. also has a Cruise Support segment that represents its portfolio of port destinations and private islands, which are operated for the benefit of its cruise brands. In addition to its cruise operations, Co. owns Holland America Princess Alaska Tours, the tour company in Alaska and the Canadian Yukon, which complements Co.'s Alaska cruise operations.

Chaparral Energy, Inc.

Corvus Pharmaceuticals

Corvus Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies. The company develops small molecules that are designed to selectively inhibit the binding of immunosuppressive adenosine to either A2A receptors or to A2B receptors. The company's initial product candidate, ciforadenant, is an oral, small molecule antagonist of the A2A receptor for adenosine. The company's second clinical product candidate, CPI-006, is an anti-CD73 monoclonal antibody that is designed to both inhibit the production of adenosine and stimulate various immune cells. The company's third clinical product candidate, CPI-818, is a selective, covalent inhibitor of ITK.

Elevate Credit

Elevate Credit provides online credit solutions to consumers in the United States and the United Kingdom. The company's online credit products are: Rise, which is a product available in various United States states as either state-licensed installment loan product, credit services organization-originated installment loan product, line of credit product, or installment loan product originated by a third-party bank; Elastic, which is a line of credit product originated by a third-party bank and provided in the United States.; Sunny, an installment loan product available in the United Kingdom; and Today Card, which is a credit card product originated by a third-party bank in the United States.

Eloxx Pharmaceuticals Inc.

ENERGOUS CORP

Energous has developed its WattUp? wireless power technology, consisting of semiconductor chipsets, software controls, hardware designs and antennas, that enables radio frequency (RF) based charging for electronic devices. The WattUp technology has a spectrum of capabilities, including contact-based wireless charging and wireless charging at various distances, and in some use cases mobility charging. The company is developing solutions that charges electronic devices by surrounding them with a RF energy pocket. For non-contact applications, the company's transmitter technology is able to mesh into a wire-free charging network that will allow users to charge their devices as they move about some space.

Eventbrite

Eventbrite is engaged in creating a technology platform to enable creators to solve the challenges associated with creating live experiences. The company's platform integrates components needed to plan, promote and produce live events. The company charges creators on a per-ticket basis when an attendee purchases a paid ticket for an event. The company designed its platform for various creators, regardless of category, country, size or type of event. The company enables events ranging from fundraisers, seminars, wellness activities and music festivals to classes and cultural celebrations all over the world.

Exela Technologies Inc.

Exela Technologies is a provider of transaction processing solutions, enterprise information management, document management and digital business process services. The company has three segments: Information and Transaction Processing, which provides solutions and services designed to aid businesses in information capture, processing, decisioning and distribution; Healthcare Solutions, which operate and maintain a consulting and outsourcing business focusing on both the healthcare provider and payer markets; and Legal and Loss Prevention Services, which provide a line of legal services in connection with class action, bankruptcy labor, claims adjudication and employment and other legal matters.

Eyenovia Inc

Eyenovia is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing the company's patented piezo-print delivery technology, branded the Optejet?. The company's MicroStat is a fixed combination formulation of phenylephrine-tropicamide for mydriasis (pupil dilation). MicroPine is a topical therapy for the treatment of progressive myopia. MicroProst is a latanoprost formulation for lowering intraocular pressure in patients with ocular hypertension, primary open angle glaucoma, and chronic angle closure glaucoma. MicroTears is the company's over-the-counter product candidate for hyperemia (red eye), pruritis (itch) and dry eye.

GENOCEA BIOSCIENCES

Genocea Biosciences is a biopharmaceutical company that discovers and develops cancer vaccines. The company uses its platform, AnTigen Lead Acquisition System (ATLAS?), to recall a patient's pre-existing CD4+ and CD8+ T cell immune responses to their tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. The company's product candidate, GEN-003, an immunotherapy for the treatment of genital herpes. The company's preclinical immuno-oncology program, GEN-009, a neoantigen cancer vaccine. The GEN-009 program uses ATLAS to identify patient neoantigens, or newly formed antigens unique to each patient, that are associated with that individual's tumor.

Greif Class A

Greif is a producer of industrial packaging products and services. The company's segments are: Rigid Industrial Packaging and Services, which products including steel, fibre and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, and transit protection products; Paper Packaging and Services, which produces and sells containerboard, corrugated sheets, corrugated containers and other corrugated products; Flexible Products and Services, which produces flexible intermediate bulk containers and related services; and Land Management, which is focused on the harvesting and regeneration of the company's United States timber properties.

Hertz Global Holdings, Inc.

i3 Verticals

i3 Verticals is a holding company. Through its subsidiaries, the company provides integrated payment and software solutions to small-and medium-sized businesses and organizations in vertical markets. The company's payment processing services enable clients to accept electronic payments, facilitating the exchange of funds and transaction data between clients, financial institutions and payment networks. The company has two reportable segments: Merchant Services, which provides payment solutions to businesses and organizations; and Proprietary Software and Payments, which provides embedded payment solutions to its clients through company-owned software.

Immunicum AB

Immunicum AB is a Sweden-based company principally engaged in the biopharmaceutical sector. The Company develops immunotherapy for therapeutic treatment of cancer and infectious diseases. The Company uses therapeutic vaccines to treat an already existing disease and is thus given to the already sick patients; therapeutic cancer vaccines administered to patients in order to delay or stop tumor cell growth, shrink tumors, prevent relapse, or to kill cancer cells that could not be eliminated with other treatments. The Company has several technology platforms, such as The Combig, Intuvax@, Subcuvax@ and The CD70, among others. The Company has several projects which are related to kidney cancer and liver cancer, among others.

Inuvo Inc

Inuvo is an internet advertising technology and digital publishing company that develops technology to deliver content and advertisements over the internet. The company has two segments: Partner Network, which recruits online publishers and provides them an advertising delivery service, the primary brands for which are ValidClick and SearchLinks©; and Owned and Operated Network, which designs, builds and markets consumer websites and applications, and is consists of the company's main online property marketed under the ALOT brand and a number of other websites targeted at demographics like EARNSPENDLIVE and sites designed for generating leads in a specific market vertical like ASKTHIS for automotive.

Kaixin Auto Holdings (N Shares)

Kayne Anderson MLP Investment Co.

Libbey Inc.

Libbey is engaged in the design, production and sale of tableware and other products. The company's products include glassware products, glass tableware, ceramicware, metalware and other tabletop products. Glass tableware products include products such as tumblers, stemware, mugs, bowls, vases, salt and pepper shakers, shot glasses, canisters, candleholders and other items. Other glass products include storageware, serveware, bakeware, handmade glass tableware and components such as blender jars and mixing bowls sold to original equipment manufacturers. The company also provides a range of ceramic dinnerware products. These include plates, bowls, platters, cups, saucers and other tabletop accessories.

Motus GI Holdings

Motus GI Holdings is a development stage company. The company has developed the Pure-Vu system, a medical device. The Pure-Vu System is indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The device integrates with standard and slim colonoscopes to enable cleansing during the procedure while preserving established procedural workflow and techniques by irrigating the colon and evacuating the irrigation fluid (water), feces and other bodily fluids and matter.

NetApp Inc.

NetApp is the data authority for the hybrid cloud. The company's product, services and solutions portfolio include: cloud data services, which include the NetApp Data Fabric, which manages, secures, and protects the data of its customers from on-premises to public to hybrid cloud; cloud infrastructure, which helps customers build cloud-architected data centers; storage systems and software, which enables customers to modernize their IT architectures with cloud-connected flash to free the resources necessary; and support services, which enable a portfolio of technical services including independent support services, support account managers, residency services, and managed services.

OncoSec Medical

Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals is an oncology company focused on the development and commercialization of medicines and artificial intelligence to find, fight and follow cancer. The company's product candidates include: AZEDRA, which is a radiotherapeutic for the treatment of adult and pediatric patients 12 years and older with iobenguane scan positive or metastatic pheochromocytoma or paraganglioma who require systemic anticancer therapy; and PyL?, which is a fluorinated prostate-specific membrane antigen-targeted PET imaging agent that enables visualization of both bone and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer.

Prosperity Bancshares, Inc.

RiceBran Technologies

RiceBran Technologies is an ingredient company serving food, animal nutrition and specialty markets focused on processing and marketing of healthy, natural and nutrient dense products derived from raw rice bran, an underutilized by-product of the rice milling industry. The company converts raw rice bran into various products including: stabilized rice bran (SRB); RiBalance, a rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious, carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and its family of ProRyza products, which includes derivatives composed of protein and protein/fiber blends.

Rubius Therapeutics

Rubius Therapeutics is a therapeutics company focused on using its platform to develop red cell therapeutics for the treatment of patients with severe diseases. The company is developing a class of cellular medicines, called Red Cell Therapeutics? for patients with cancer and autoimmune diseases based on two therapeutic modalities - potent cell-cell interaction and tolerance induction. The company's product candidates pipeline comprised of: RTX-240 for the treatment of solid tumors; RTX-240 for the treatment of acute myeliod leukemia; RTX-321 artificial antigen presenting cell program for the treatment of solid tumors; RTX-224 for the treatment of solid tumors; and RTX-T1D for the treatment of diabetes.

Safestore Holdings plc

Safestore Holdings is engaged in the rental of self-storage space and the sale of ancillary products such as insurance and merchandise (for example, packing materials and padlocks) in both the U.K. and Paris.

Savara

Savara is an orphan lung disease company. The company's drug development pipeline comprises Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor in development for pulmonary alveolar proteinosis and in development for nontuberculous mycobacterial lung infection; and AeroVanc, an inhaled vancomycin for treatment of persistent methicillin-resistant Staphylococcus aureus lung infection in individuals living with cystic fibrosis.

The Gabelli Healthcare & WellnessRx Trust

The Medicines Company

Thor Industries Inc.

Thor Industries is a manufacturer of recreational vehicles. The company has three segments: North American Towable Recreational Vehicles, which consists of: Airstream (towable), Heartland (including Bison, Cruiser RV and DRV), Jayco (including Jayco towable, Starcraft and Highland Ridge), Keystone (including CrossRoads and Dutchmen) and KZ (including Venture RV); North American Motorized Recreational Vehicle, which consists of: Airstream (motorized), Jayco (including Jayco motorized and Entegra Coach) and Thor Motor Coach; and European Recreational Vehicles, which consists of the Erwin Hymer Group business.

Tutor Perini Corporation

Tutor Perini is a construction company. The company operates in three segments: Civil, which focuses on public works construction and the replacement and reconstruction of infrastructure; Building, which provides services to various building markets for private and public works customers, including hospitality and gaming, transportation, health care, commercial offices, sports and entertainment, education, correctional facilities, biotech and pharmaceutical, among others; and Specialty Contractors, which focuses on electrical, mechanical, plumbing, heating, ventilation and air conditioning, fire protection systems and pneumatically placed concrete for civil and building construction projects.

United Therapeutics Corporation

United Therapeutics is a biotechnology company. The company markets and sells four commercial therapies to treat pulmonary arterial hypertension (PAH): Remodulin? (treprostinil) Injection; Tyvaso? (treprostinil) Inhalation Solution; Orenitram? (treprostinil) Extended-Release Tablets; and Adcirca? (tadalafil) Tablets. The company also markets and sells an oncology product, Unituxin? (dinutuximab) Injection for treatment of high-risk neuroblastoma. The company also engages in research and development of new indications and formulations and delivery devices for its existing products, as well as new products to treat PAH and other conditions. The company also engages in organ transplantation-related technologies.

Vermillion

Vermillion is engaged in the discovery, development and commercialization of diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve outcomes for women. The company concentrates its development of diagnostic tests for gynecologic disease, with an initial focus on ovarian cancer. The company's primary product, OVA1, is a blood test designed to, in addition to a physician's clinical assessment of a woman with a pelvic mass, identify women who are at high risk of having a malignant ovarian tumor prior to planned surgery. The company's ASPiRA LABS engages in applying biomarker-based technologies to address needs in the management of gynecologic cancers and disease.

VSE Corp

VSE is a services and supply chain management company. The company's segments are: Supply Chain Management Group, which provides sourcing, acquisition, scheduling, transportation, shipping, logistics, data management, and other services; Aviation Group, which provides parts supply and distribution, supply chain solutions, and maintenance, repair, and overhaul services; and Federal Services Group, which provides foreign military sales services, refurbishment services, fleet-wide ship and aircraft support, aircraft sustainment and maintenance, and other technical, management, engineering, logistics, maintenance, configuration management, prototyping, technology, and field support services.

Washington Prime Group Inc.

Washington Prime Group operates as a self-administered and self-managed real estate investment trust. Washington Prime Group, L.P. (WPG L.P.) is the company's majority-owned limited partnership subsidiary that owns, develops, and manages, through its affiliates, all of the company's real estate properties and other assets. The company is the sole general partner of WPG L.P. The company owns, develops and manages enclosed retail properties and open air properties. The company's assets consist of material interests in shopping centers in the United States.

Zuora

Zuora is a cloud-based subscription management platform. The company's solution is the system of record for its customers' subscription business models and consists of three components: the company's Zuora Central Platform, which platform acts as an intelligent subscription management hub, allowing customers to orient operations around it to create a process designed for subscription business models; other products, which consists of Zuora Billing and Zuora RevPro; and an application marketplace, which the Zuora Marketplace provides industry-specific tools and third-party applications that extend the company's capabilities for its customers.

Provider
InsiderInsights.com
InsiderInsights.com

Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.

Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.

InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.

Analysts
Jonathan Moreland

Other Reports on these Companies
Other Reports from InsiderInsights.com

ResearchPool Subscriptions

Get the most out of your insights

Get in touch